|
From the Departments of Medicine and of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ont. (Devereaux, Cook, Guyatt), the Department of Medicine, University of California, San Francisco, San Francisco, Calif. (Goldman), the Department of Medicine, University of Western Ontario, London, Ont. (Gilbert), the Department of Anaesthesia and Pain Management, Royal Melbourne Hospital, and the Department of Pharmacology, University of Melbourne, Melbourne, Australia (Leslie)
Correspondence to: Dr. P.J. Devereaux, Department of Clinical Epidemiology and Biostatistics, Faculty of Health Sciences, Rm. 2C8, McMaster University, 1200 Main St. W, Hamilton ON L8N 3Z5; fax 905 905 526-1353; philipj{at}mcmaster.ca
Abstract
THIS IS THE FIRST OF 2 ARTICLES EVALUATING cardiac events in patients undergoing noncardiac surgery. In this article, we review the magnitude of the problem, the pathophysiology of these events, approaches to risk assessment and communication of risk. The number of patients undergoing noncardiac surgery worldwide is growing, and annually 500 000 to 900 000 of these patients experience perioperative cardiac death, nonfatal myocardial infarction (MI) or nonfatal cardiac arrest. Although the evidence is limited, a substantial proportion of fatal perioperative MIs may not share the same pathophysiology as nonoperative MIs. A clearer understanding of the pathophysiology is needed to direct future research evaluating prophylactic, acute and long-term interventions. Researchers have developed tools to facilitate the estimation of perioperative cardiac risk. Studies suggest that the Lee index is the most accurate generic perioperative cardiac risk index. The limitations of the studies evaluating the ability of noninvasive cardiac tests to predict perioperative cardiac risk reveals considerable uncertainty as to the role of these popular tests. Similarly, there is uncertainty as to the predictive accuracy of the American College of Cardiology / American Heart Association algorithm for cardiac risk assessment. Patients are likely to benefit from improved estimation and communication of cardiac risk because the majority of noncardiac surgeries are elective and accurate risk estimation is important to allow informed patient and physician decision-making.
This article has been cited by other articles:
![]() |
K. Leslie, P. S. Myles, A. Forbes, and M. T. V. Chan The Effect of Bispectral Index Monitoring on Long-Term Survival in the B-Aware Trial Anesth. Analg., March 1, 2010; 110(3): 816 - 822. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-Y. Liu, J. D. Muehlschlegel, T. E. Perry, A. A. Fox, C. D. Collard, S. C. Body, and S. K. Shernan Common genetic variants on chromosome 9p21 predict perioperative myocardial injury after coronary artery bypass graft surgery J. Thorac. Cardiovasc. Surg., February 1, 2010; 139(2): 483 - 488. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. N Wijeysundera, W S. Beattie, P. C Austin, J. E Hux, and A. Laupacis Non-invasive cardiac stress testing before elective major non-cardiac surgery: population based cohort study BMJ, January 28, 2010; 340(jan28_3): b5526 - b5526. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Chopra, S. A. Flanders, J. B. Froehlich, W. C. Lau, and K. A. Eagle Perioperative Practice: Time to Throttle Back Ann Intern Med, January 5, 2010; 152(1): 47 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-H Choi, D K Cho, Y-B Song, J-Y Hahn, S Choi, H-C Gwon, D-K Kim, S H Lee, J K Oh, and E-S Jeon Preoperative NT-proBNP and CRP predict perioperative major cardiovascular events in non-cardiac surgery Heart, January 1, 2010; 96(1): 56 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Karthikeyan, R. A. Moncur, O. Levine, D. Heels-Ansdell, M. T.V. Chan, P. Alonso-Coello, S. Yusuf, D. Sessler, J. C. Villar, O. Berwanger, et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J. Am. Coll. Cardiol., October 20, 2009; 54(17): 1599 - 1606. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Daban, G. P. De Saint Maurice, E. Batjom, E. Falzone, and S. Ausset Postoperative myocardial damages are a key issue in patients' outcome after hip fracture Age Ageing, July 1, 2009; 38(4): 488 - 489. [Full Text] [PDF] |
||||
![]() |
D. E.G. Griesdale, R. J. de Souza, R. M. van Dam, D. K. Heyland, D. J. Cook, A. Malhotra, R. Dhaliwal, W. R. Henderson, D. R. Chittock, S. Finfer, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data Can. Med. Assoc. J., April 14, 2009; 180(8): 821 - 827. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Dai, A. Lee, L. A. H. Critchley, and P. F. White Does Thromboelastography Predict Postoperative Thromboembolic Events? A Systematic Review of the Literature Anesth. Analg., March 1, 2009; 108(3): 734 - 742. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lippi, G. L. Salvagno, A. M. Minicozzi, M. Montagnana, C. Cordiano, G. De Manzoni, and G. C. Guidi Biomarkers of Myocardial Infarction in Patients Undergoing Gastrointestinal Cancer Surgery Lab Med, February 1, 2009; 40(2): 91 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. HARTE and A. K. JAFFER Perioperative beta-blockers in noncardiac surgery: Evolution of the evidence Cleveland Clinic Journal of Medicine, July 1, 2008; 75(7): 513 - 519. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, H. B. Ward, T. E. Moritz, F. S. Apple, S. Goldman, G. Pierpont, G. C. Larsen, B. Hattler, K. Shunk, F. Littooy, et al. Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial Eur. Heart J., February 1, 2008; 29(3): 394 - 401. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Walsh, T. Tang, U. Sadat, D. P. Dutka, and M. E. Gaunt Cardioprotection by remote ischaemic preconditioning Br. J. Anaesth., November 1, 2007; 99(5): 611 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chang, M. Sarkiss, K. S. Won, J. Swafford, L. Broemeling, and I. Gayed Preoperative Risk Stratification Using Gated Myocardial Perfusion Studies in Patients with Cancer J. Nucl. Med., March 1, 2007; 48(3): 344 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Liu and C. L. Wu Effect of Postoperative Analgesia on Major Postoperative Complications: A Systematic Update of the Evidence Anesth. Analg., March 1, 2007; 104(3): 689 - 702. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. G Noordzij, E. Boersma, F. Schreiner, M. D Kertai, H. H H Feringa, M. Dunkelgrun, J. J Bax, J. Klein, and D. Poldermans Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery Eur. J. Endocrinol., January 1, 2007; 156(1): 137 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S Kapoor, H. Kanji, J. Buckingham, P J Devereaux, and F. A McAlister Strength of evidence for perioperative use of statins to reduce cardiovascular risk: systematic review of controlled studies BMJ, December 2, 2006; 333(7579): 1149 - 1149. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Auerbach and L. Goldman Assessing and Reducing the Cardiac Risk of Noncardiac Surgery Circulation, March 14, 2006; 113(10): 1361 - 1376. [Full Text] [PDF] |
||||
![]() |
P.J. Devereaux, L. Goldman, S. Yusuf, K. Gilbert, K. Leslie, and G. H. Guyatt Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review Can. Med. Assoc. J., September 27, 2005; 173(7): 779 - 788. [Abstract] [Full Text] [PDF] |
||||
Read all eLetters